Buy Exondys 51 100mg/2ml Eteplirsen

Exondys 51 100mg/2ml (Eteplirsen) is a prescription medication supplied in vials for injection. It is designed for use under medical supervision to address certain genetic conditions. This product is stored as directed by healthcare professionals.

Strength

100 mg/2 mL

Pack Size

Manufacturer / TM Owner

Sarepta Therapuetics

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Eteplirsen is used to treat Duchenne muscular dystrophy in patients with a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. It helps support muscle function by targeting the underlying genetic cause. This medication is part of a broader approach to managing symptoms in specific patient groups.

Side Effects

Patients using Eteplirsen may experience improved muscle function over time, though individual responses vary. The medication works by helping the body produce a functional version of the dystrophin protein, which is often missing in Duchenne muscular dystrophy. Regular monitoring by a healthcare provider is recommended to assess progress.

Precautions & Warnings

Eteplirsen should only be administered by a healthcare professional in a clinical setting. Patients should discuss their full medical history, including allergies and current medications, with their doctor before starting treatment. Keep vials stored as directed to maintain potency and safety.

Avoid Interactions

Limited information is available on drug interactions with Eteplirsen. However, patients should inform their healthcare provider about all medications, supplements, or herbal products they are using. Caution is advised when combining with other therapies that may affect muscle function or kidney health.

References

Frequently Asked Questions

Exondys 51 is used to treat Duchenne muscular dystrophy in patients with a specific genetic mutation.

Exondys 51 is given as an intravenous injection by a healthcare professional.

Common side effects may include headache, vomiting, and joint pain.

Patients should consult their doctor before combining Exondys 51 with other treatments.

No, Exondys 51 requires a prescription and is administered under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.